Evidence map›Paper›PMID 40531319›Full record

ArticleEuropean radiology2025

Contrast-enhanced CT-based prediction models for early intervention efficacy and in-hospital mortality risk in acute necrotizing pancreatitis with persistent organ failure.

Minchun Bu, Yun Zhang, Faxi Chen, Xiaochun Xie, Kaiming Li, Bo Ye, Lu Ke, Zhihui Tong, Weiqin Li, Gang Li

Abstract read
PubMed Publisher
In one paragraph

Article in European radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Minchun Bu *Medical College of Yangzhou University, Yangzhou, China.
Yun Zhang *Medical College of Yangzhou University, Yangzhou, China.
Faxi Chen *Department of Critical Care Medicine, Jinling Hospital, Medical School of Nanjing Medical University, Nanjing, China.
Xiaochun XieDepartment of critical care medicine, Nanjing Drum Tower Hospital, Nanjing, China.
Kaiming LiJinling Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, China.
Bo YeDepartment of Critical Care Medicine, Center of Severe Acute Pancreatitis (CSAP), Jinling Hospital, Medical School of Nanjing University, Nanjing, China. bobmaster819@126.com.
Lu KeDepartment of Critical Care Medicine, Center of Severe Acute Pancreatitis (CSAP), Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Zhihui TongDepartment of Critical Care Medicine, Center of Severe Acute Pancreatitis (CSAP), Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Weiqin LiMedical College of Yangzhou University, Yangzhou, China. ctgchina@medbit.cn.
Gang LiDepartment of Critical Care Medicine, Center of Severe Acute Pancreatitis (CSAP), Jinling Hospital, Medical School of Nanjing University, Nanjing, China. nju8icu@126.com.ORCID http://orcid.org/0009-0009-6533-3758

Funding

The clinical special research fund of the Affiliated Jinling Hospital of Nanjing University Medical School Grant no. 22LCYY-QH3
6 · The paper itself

Abstract

objectiveTo develop contrast-enhanced CT-based nomograms for predicting early intervention efficacy and in-hospital mortality in acute necrotizing pancreatitis (ANP) with persistent organ failure (POF). MATERIALS AND

methodsThis retrospective study analyzed 164 ANP patients with POF (110 in the training cohort, 54 in the validation cohort). The Sequential Organ Failure Assessment (SOFA) score was used to evaluate organ dysfunction severity. Contrast-enhanced CT parameters included mean and range CT numbers (HU) of acute necrotic collections (ANC) across anatomical regions, as well as pancreatic necrosis volume (PNV). LASSO regression identified predictors for early intervention efficacy and mortality. Nomograms were assessed using receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis.

resultsEarly intervention efficacy predictors included intra-abdominal pressure, cardiovascular hemodynamic changes, and PNV increase. The model demonstrated good predictive performance, with an area under the ROC curve (AUC) of 0.848 (95% CI: 0.769-0.927) in the training cohort and 0.796 (95% CI: 0.644-0.947) in the validation cohort. In-hospital mortality predictors were SOFA score, cardiovascular hemodynamic changes, mean CT number of ANC at the right anterior pararenal space, and CT number range at the left paracolic gutter. The model showed AUCs of 0.918 (training cohort, 95% CI: 0.864-0.971) and 0.860 (validation cohort, 95% CI: 0.801-0.919).

conclusionANP patients with intra-abdominal hypertension or significant PNV increase who maintain cardiovascular hemodynamic stability are more likely to benefit from early intervention. An elevated SOFA score, persistent cardiovascular failure, and ANC with poor homogeneity or drainage difficulty are risk factors for in-hospital mortality. KEY POINTS: Question The optimal timing for early invasive intervention remains controversial in ANP with POF. Findings Nomogram models integrating organ dysfunction severity and contrast-enhanced CT imaging features can predict treatment response and clinical outcomes in ANP patients with POF. Clinical relevance Our prediction models can identify patients who may benefit from early invasive intervention and assess in-hospital mortality risk for the entire cohort, providing a practical tool to guide clinical decision-making.

Indexed as

Contrast MediaHospital MortalityMultiple Organ FailurePancreatitis, Acute NecrotizingTomography, X-Ray ComputedAdultAgedFemaleHumansMaleMiddle AgedNomogramsOrgan Dysfunction ScoresPredictive Value of TestsRetrospective StudiesContrast MediaAcute necrotizing pancreatitisCTEarly interventionPersistent organ failurePredictive model

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.